We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

256 hedge funds and large institutions have $561M invested in Editas Medicine in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 74 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.94% more ownership

Funds ownership: 66.23% → 69.17% (+2.9%)

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

0% more funds holding

Funds holding: 256 → 256 (0)

4% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 74

5% less call options, than puts

Call options by funds: $19.9M | Put options by funds: $20.8M

35% less capital invested

Capital invested by funds: $862M → $561M (-$301M)

Holders
256
Holders Change
–
Holders Change %
0%
% of All Funds
4.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
71
Reduced
74
Closed
35
Calls
$19.9M
Puts
$20.8M
Net Calls
-$968K
Net Calls Change
+$6.68M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$32.2M
2
WP
Woodline Partners
California
+$13.3M
3
Citadel Advisors
Citadel Advisors
Florida
+$9.02M
4
PHS
PFM Health Sciences
California
+$8.44M
5
BlackRock
BlackRock
New York
+$6.02M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$17.2M
2
Millennium Management
Millennium Management
New York
-$7.99M
3
AIM
ARK Investment Management
Florida
-$7.29M
4
CU
CQS (US)
New York
-$6.41M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$4.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
26
Rafferty Asset Management
New York
$4.06M -$160K -11,964 -3%
GAA
27
Green Alpha Advisors
Colorado
$4.02M +$3.91M +291,531 +602%
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$3.72M +$4.21M +314,247 New
Mirae Asset Global Investments
29
Mirae Asset Global Investments
South Korea
$3.63M +$1.2M +89,458 +41%
Bank of America
30
Bank of America
North Carolina
$3.49M -$137K -10,193 -3%
UBS Group
31
UBS Group
Switzerland
$3.32M +$526K +39,281 +16%
SOMRS
32
State of Michigan Retirement System
Michigan
$3.24M – – –
LOAMS
33
Lombard Odier Asset Management (Switzerland)
Switzerland
$3.07M -$1.62M -121,131 -32%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$3.06M -$658K -49,090 -16%
AIM
35
ARK Investment Management
Florida
$2.88M -$7.29M -543,915 -68%
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.79M +$720K +53,731 +29%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.76M -$749K -55,914 -19%
CSS
38
Cubist Systematic Strategies
Connecticut
$2.7M +$2.87M +214,243 +1,564%
SSA
39
Schonfeld Strategic Advisors
New York
$2.21M +$2.5M +186,844 New
Wells Fargo
40
Wells Fargo
California
$2.2M +$244K +18,239 +11%
SCM
41
Shelton Capital Management
Colorado
$2.01M – – –
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.91M – – –
Legal & General Group
43
Legal & General Group
United Kingdom
$1.87M +$373K +27,835 +21%
Millennium Management
44
Millennium Management
New York
$1.79M -$7.99M -596,501 -80%
Thrivent Financial for Lutherans
45
Thrivent Financial for Lutherans
Minnesota
$1.77M +$1.41M +105,207 +235%
GCM
46
Graham Capital Management
Connecticut
$1.7M +$1.93M +144,080 New
RJA
47
Raymond James & Associates
Florida
$1.64M -$290K -21,642 -14%
PAMS
48
Pictet Asset Management (Switzerland)
Switzerland
$1.57M +$306K +22,835 +21%
Jane Street
49
Jane Street
New York
$1.53M +$923K +68,879 +115%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$1.2M +$385K +28,708 +40%
1
2
3 4 5

EDIT Hedge Fund Activity: Q2 2022 in Review

256 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2022, worth a combined $561M — down 35% from $862M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new EDIT positions and 35 closed out — a net gain of 3 holders — while 71 added to existing stakes and 74 trimmed.

The largest buyer was State Street, adding an estimated $32.2M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $17.2M sold.

  • 256 institutional investors held Editas Medicine (EDIT) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $561M of Editas Medicine stock for Q2 2022, down 35% quarter-over-quarter.
  • 38 funds opened new Editas Medicine positions in Q2 2022 and 35 closed out, a net change of +3 holders.
  • The largest Editas Medicine buyer in Q2 2022 was State Street, an estimated $32.2M added.
  • The largest Editas Medicine seller in Q2 2022 was Renaissance Technologies, an estimated $17.2M sold.

Based on aggregated 13F filings for Q2 2022.